BeyondSpring Inc. Proceeds from Interest Received
BeyondSpring Inc. (BYSI) reported Proceeds from Interest Received of $45.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromInterestReceived · last filed 2026-08-14
- BeyondSpring Inc. proceeds from interest received for the quarter ending 2026-06-30 was $6.00K, a 96.39% decline year-over-year.
- BeyondSpring Inc. proceeds from interest received for the quarter ending 2026-03-31 was $39.00K, a 77.27% increase year-over-year.
- BeyondSpring Inc. proceeds from interest received for the quarter ending 2025-12-31 was $48.00K, a 51.02% decline year-over-year.
- BeyondSpring Inc. proceeds from interest received for the quarter ending 2025-09-30 was $75.00K, a 2400.00% increase year-over-year.
- BeyondSpring Inc. proceeds from interest received for fiscal 2025 was $311.00K, a 110.14% increase from fiscal 2024.
- BeyondSpring Inc. proceeds from interest received for fiscal 2024 was $148.00K, a 67.97% decline from fiscal 2023.
- BeyondSpring Inc. proceeds from interest received for fiscal 2023 was $462.00K.
| Period end | Proceeds from Interest Received 3 month | Proceeds from Interest Received 6 month | Proceeds from Interest Received 9 month | Proceeds from Interest Received 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $45.00K 10-Q · filed 2026-08-14 | $93.00K derived: sum of 3 quarters · filed 2026-08-14 | $168.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $39.00K 10-Q · filed 2026-05-13 | $87.00K derived: sum of 2 quarters · filed 2026-05-13 | $162.00K derived: sum of 3 quarters · filed 2026-05-13 | $328.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $123.00K derived: sum of 2 quarters · filed 2026-03-25 | $289.00K derived: sum of 3 quarters · filed 2026-08-14 | $311.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $241.00K derived: sum of 2 quarters · filed 2026-08-14 | $263.00K 10-Q · filed 2025-11-12 | $361.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $188.00K 10-Q · filed 2026-08-14 | $286.00K derived: sum of 3 quarters · filed 2026-08-14 | $289.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $22.00K 10-Q · filed 2026-05-13 | $120.00K derived: sum of 2 quarters · filed 2026-05-13 | $123.00K derived: sum of 3 quarters · filed 2026-05-13 | $138.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $101.00K derived: sum of 2 quarters · filed 2026-03-25 | $116.00K derived: sum of 3 quarters · filed 2026-03-25 | $148.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $18.00K derived: sum of 2 quarters · filed 2025-11-12 | $50.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $47.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $32.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $462.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | $136.00K 20-F · filed 2023-04-18 | |||
| 2021-12-31 | $16.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $42.00K derived: sum of 2 quarters · filed 2023-04-18 | $74.00K derived: sum of 3 quarters · filed 2023-04-18 | $98.00K 20-F · filed 2023-04-18 |
| 2021-09-30 | $26.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $58.00K derived: sum of 2 quarters · filed 2021-12-30 | $82.00K 6-K · filed 2021-12-30 | $92.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-06-30 | $32.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | $56.00K 6-K · filed 2021-09-10 | $66.00K derived: sum of 3 quarters · filed 2023-04-18 | $75.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-03-31 | $24.00K 6-K · filed 2021-06-16 | $34.00K derived: sum of 2 quarters · filed 2023-04-18 | $43.00K derived: sum of 3 quarters · filed 2023-04-18 | $73.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2020-12-31 | $10.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $19.00K derived: sum of 2 quarters · filed 2023-04-18 | $49.00K derived: sum of 3 quarters · filed 2023-04-18 | $166.00K 20-F · filed 2023-04-18 |
| 2020-09-30 | $9.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $39.00K derived: sum of 2 quarters · filed 2021-12-30 | $156.00K 6-K · filed 2021-12-30 | |
| 2020-06-30 | $30.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | $147.00K 6-K · filed 2021-09-10 | ||
| 2020-03-31 | $117.00K 6-K · filed 2021-06-16 | |||
| 2019-12-31 | $131.00K 20-F · filed 2022-04-14 | |||
| 2018-12-31 | $234.00K 20-F · filed 2021-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |